ABBV
Abbvie Inc
NYSE · Biotechnology
$223.43
+4.41 (+2.01%)
S&P 500
Mega-Cap Stocks
Blue Chip Stocks
Biotech Stocks
Healthcare Stocks
Best Dividend Stocks
Highest Dividend Yield
Performance
1D
—
1W
-0.98%
1M
+1.54%
3M
-0.77%
6M
+10.90%
1Y
+17.38%
YTD
-2.56%
Open$218.75
Previous Close$219.02
Day High$225.82
Day Low$218.50
52W High$244.81
52W Low$164.39
Volume6.06M
Avg Volume7.77M
Market Cap394.89B
P/E Ratio165.36
EPS$1.35
SectorBiotechnology
Volume Analysis
0.78x average volume
Technical Indicators
SMA 50
$224.02
Below
SMA 200
$209.64
Above
RSI (14)
62.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
37 analysts
Price Target
+15.3% upside
Current
$223.43
$223.43
Target
$257.58
$257.58
$173.19
$257.58 avg
$337.66
Key Financials
| FY 2026 | FY 2026 | FY 2025 | |
|---|---|---|---|
| Revenue | 56.16B | 56.16B | 56.11B |
| Net Income | 4.26B | 4.26B | 3.84B |
| Profit Margin | 7.6% | 7.6% | 7.2% |
| EBITDA | 6.64B | 6.64B | 6.30B |
| Free Cash Flow | — | — | — |
| Rev Growth | +0.1% | +0.1% | +0.1% |
| Debt/Equity | 20.19 | 20.19 | 20.19 |
Dividend
Dividend Yield3.16%
Annual Dividend$6.24
Payout Ratio257.7%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |
| INSM | Insmed Inc | $149.86 | -0.77% | — | 31.96B |